Étienne Gaudette
Dados Biográficos
| ID | 5546032 |
|---|---|
| NOME | Étienne Gaudette |
| PRENOMES | Étienne |
| SOBRENOME | Gaudette |
| ASSINATURA | GAUDETTE É |
| AFILIAÇÕES | University of Toronto |
| ORCID | 0000-0003-0359-2083 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 4 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 4 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2017 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2025 |
| ÍNDICE H | 0 |
The association between drug shortages and prices across 74 countries
BACKGROUND: Drug shortages are a global concern that poses risks to clinical care and health systems. Lower prices and market pressures are often cited as drivers of drug shortages; thus, a commonly proposed policy lever is to increase drug prices. However, global evidence to evaluate the association between shortages and prices is lacking. This research aims to fill the gap by examining the global markets of drug shortages. METHOD: We included 2…
Competition in International Generic Drug Markets
This cross-sectional study compares the small molecule generic drug markets of a group of high-income countries with similar pharmaceutical regulatory environments
Covid-19’s Limited Impact on Drug Shortages in Canada
Using data from the Drug Shortages Canada website, we ask whether the first months of the coronavirus disease 2019 (COVID-19) pandemic were associated with a significant increase in drug shortages in Canada. We find an increase of 147 shortages (32 percent) reported by manufacturers during March and April 2020 relative to the same months in previous years. The upsurge was concentrated during the two-week period from 25 March to 7 April 2020, afte…
Using Self-reports or Claims to Assess Disease Prevalence
BACKGROUND: Two common ways of measuring disease prevalence include: (1) using self-reported disease diagnosis from survey responses; and (2) using disease-specific diagnosis codes found in administrative data. Because they do not suffer from self-report biases, claims are often assumed to be more objective. However, it is not clear that claims always produce better prevalence estimates. OBJECTIVE: Conduct an assessment of discrepancies between s…
Sem obras proeminentes nesta página.
Using Self-reports or Claims to Assess Disease Prevalence
BACKGROUND: Two common ways of measuring disease prevalence include: (1) using self-reported disease diagnosis from survey responses; and (2) using disease-specific diagnosis codes found in administrative data. Because they do not suffer from self-report biases, claims are often assumed to be more objective. However, it is not clear that claims always produce better prevalence estimates. OBJECTIVE: Conduct an assessment of discrepancies between s…
Covid-19’s Limited Impact on Drug Shortages in Canada
Using data from the Drug Shortages Canada website, we ask whether the first months of the coronavirus disease 2019 (COVID-19) pandemic were associated with a significant increase in drug shortages in Canada. We find an increase of 147 shortages (32 percent) reported by manufacturers during March and April 2020 relative to the same months in previous years. The upsurge was concentrated during the two-week period from 25 March to 7 April 2020, afte…
Competition in International Generic Drug Markets
This cross-sectional study compares the small molecule generic drug markets of a group of high-income countries with similar pharmaceutical regulatory environments
The association between drug shortages and prices across 74 countries
BACKGROUND: Drug shortages are a global concern that poses risks to clinical care and health systems. Lower prices and market pressures are often cited as drivers of drug shortages; thus, a commonly proposed policy lever is to increase drug prices. However, global evidence to evaluate the association between shortages and prices is lacking. This research aims to fill the gap by examining the global markets of drug shortages. METHOD: We included 2…
Medicine (3 obras) · Pharmaceutical Economics and Policy (3 obras) · Business (2 obras) · Disease (2 obras) · Drug (2 obras) · Economic shortage (2 obras) · Environmental health (2 obras) · Pharmacology (2 obras) · 2019-20 coronavirus outbreak (1 obras) · Actuarial science (1 obras)